Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
1.03
0.07 (7.63%)
At close: Aug 22, 2025, 3:59 PM
1.03
0.02%
After-hours: Aug 22, 2025, 07:46 PM EDT

Ovid Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-26.43M -52.34M -54.17M 122.83M
Depreciation & Amortization
613K 1.6M 1.38M 237.08K
Stock-Based Compensation
6.28M 7.29M 6.56M 5.05M
Other Working Capital
362K 635.51K -3.06M -18.52M
Other Non-Cash Items
-36.26M -4.71M -764.94K 7.3M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-150K 2.39M -8.23M -16.81M
Operating Cash Flow
-55.96M -45.78M -55.23M 118.61M
Capital Expenditures
-71K -137.46K -1.42M -189.41K
Cash Acquisitions
n/a -10M -2.5M -1.63M
Purchase of Investments
-73.25M -112.44M -172.96M -1.63B
Sales Maturities Of Investments
128M 120M 90M 1.64B
Other Investing Acitivies
-89K -97.15K -1M -5.4M
Investing Cash Flow
54.59M -2.58M -87.88M -1.82M
Debt Repayment
n/a 30M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -21.31K
Financial Cash Flow
622K 30.54M 180.66K 904.08K
Net Cash Flow
-740K -17.83M -142.93M 117.69M
Free Cash Flow
-56.03M -45.92M -56.65M 118.42M